Search

everythinglearnresearchcommunity

for

Search:↓

Arsenic exposure from contaminated water severely damages the skin, causing hair loss, pigmentation changes, irritation, and can lead to skin cancer.

Mutations in the P2RY5 gene cause autosomal recessive woolly hair.

Melanocytes are crucial for skin pigmentation and can affect conditions like melanoma, vitiligo, and albinism, as well as hair color and hearing.

miR-195-5p reduces hair growth ability in cells by blocking a specific growth signal.

Some brain cancer cells avoid immune system detection, and certain treatments could target this to slow their growth; also, certain fat cell precursors help regenerate hair and skin after injury.

Mice that can regenerate tissue have cells that pause in the cell cycle, which is important for healing, similar to axolotls.

Mice can regenerate ear tissue without the p53 protein.

Vitamin D and its receptor are essential for hair growth, cell regulation, immune function, and heart health.

Lacking cyclin D3 reduces skin cancer growth without affecting normal skin cell growth.

The document concludes that stem cell inactivity is actively controlled and important for tissue repair and balance.

Deleting the PTEN gene in mice causes nerve cells to grow larger and heal better after injury, but may cause overgrowth and hair loss in older mice.

Deleting the MAD2L1 gene is tolerated in certain mouse cancer models.

Deleting the MAD2L1 gene in mice led to rapid tumor growth despite chromosomal instability.

Understanding where cancer cells come from helps create better prevention and treatment methods.

Abemaciclib can cause skin, hair, and nail problems, leading some patients to stop using it.

VDUP1 is found in skin and hair follicles, interacts with sciellin, and may help regulate skin cell differentiation.

New targeted cancer drugs can cause skin side effects, and managing them requires patient education and timely care.

The oncoprotein causes abnormal hair growth without increasing skin cancer risk.

Removing p16INK4a from skin cells can lead to faster and more clumped growth, which might help with hair growth.

The document concludes that careful diagnosis is crucial for chromosome 13q deletion syndrome, tamoxifen can cause reversible eye damage, finasteride may be linked to cataracts, and OCT is useful for diagnosing macular diseases.

A boy with chromosome 13q deletion syndrome developed eye cancer, a woman with breast cancer lost vision due to a rare side-effect of her treatment, a man's vision worsened after using a hair loss drug, and two rare disorders were discussed. Optical Coherence Tomography is useful for diagnosing and monitoring these conditions.

Eye exams are crucial for kids with 13q deletion syndrome, tamoxifen can cause vision loss, Propecia may lead to cataracts, Lipoid Proteinosis causes skin bumps, and OCT is useful for diagnosing macular diseases.

A baby boy with 13q deletion syndrome had eye cancer, a woman's vision improved after stopping a breast cancer drug, a man developed cataracts from using Propecia, and a rare skin disorder called Lipoid Proteinosis was discussed. Also, a tool called OCT is useful for diagnosing macular diseases.

The document discusses various eye conditions and their treatments, including a rare eye cancer in a baby, vision loss from a cancer drug, cataracts from a baldness treatment, a rare skin disorder, and a specific type of eye disease diagnosed with a special imaging technique.

Finasteride, often used for hair loss, can potentially cause cataracts.

Multiple eye conditions were studied, highlighting the importance of various imaging methods for diagnosis, the vision side effects of drugs tamoxifen and Propecia, and the usefulness of optical coherence tomography for diagnosing and monitoring macular and retinal diseases.

Taking Propecia might lead to the development of cataracts.

CDK4/6 inhibitors have improved treatment outcomes for certain advanced breast cancer patients.

Chemotherapy in children often causes hair loss, nausea, vomiting, and mood swings.

Using CDK inhibitors on rats showed a reduction in chemotherapy-caused hair loss, but later experiments could not repeat these results.